Free express shipping on orders over $200
ELITE BIOTECH

Research overview

What is BPC-157?

BPC-157 is a synthetic pentadecapeptide widely studied in laboratory research involving tissue repair, angiogenesis, and cellular response. It is not an approved therapeutic medicine.

Synthetic pentadecapeptidePredominantly preclinical

Research use only · Not for human consumption · 18+. This page describes published scientific context for laboratory and educational research. It is not medical advice or a recommendation to administer this compound.

How is BPC-157 classified in scientific research?

BPC-157 is described as a stable gastric pentadecapeptide with the sequence GEPPPGKPADDAGLV and is supplied for laboratory research.

Mechanism studied in research

Laboratory studies have investigated BPC-157 in relation to:

  • VEGFR2 Angiogenesis research.

  • Nitric Oxide Vascular and cellular signaling.

  • FAK Cell migration and tissue response.

These findings are limited to experimental research.

Research background

Current evidence for BPC-157 comes primarily from laboratory and animal research. Human clinical evidence remains limited.

Purity, testing and handling

Verify BPC-157 using the matching COA and batch documentation before laboratory use.

References

  1. 1

    Hsieh MJ, Liu HT, Wang CN, et al. Journal of Molecular Medicine. 2017. PMID: 27847966

  2. 2

    Cerovecki T, Bojanic I, Brcic L, et al. Journal of Orthopaedic Research. 2010. PMID: 20225319

  3. 3

    Sikiric P, Seiwerth S, Rucman R, et al. Current Neuropharmacology. 2016. PMID: 27138887

Primary literature and reviews linked through PubMed. Citations are provided for scientific reference and do not imply a human-use indication.

Related